心血管疾病的基因治疗:临床前景
Young Shin Lee1, Jung Ran Choi2, Jin-Bae Kim1,3
1Division of Cardiology, Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
Yonsei medical journal
|September 23, 2024
概括
心脏基因疗法对心血管疾病 (CVD) 是有前途的,但面临着低效率和免疫反应等挑战. 克服这些障碍是将临床前成功转化为有效的临床治疗心血管疾病的关键.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 心血管疾病 (CVD) 是导致死亡的主要原因,目前的治疗方法有局限性.
- 心脏基因疗法为心血管疾病管理提供了一个潜在的替代方案.
- 临床前研究显示有希望,但临床翻译仍然具有挑战性.
研究的目的:
- 审查最近关于心脏基因治疗心血管疾病的临床前和临床研究.
- 讨论阻碍临床应用的局限性和挑战.
主要方法:
- 关于临床前和临床研究的综合文献综述.
- 对基因转导效率,免疫反应和非目标效应的分析.
- 评估成功和不成功的临床试验结果.
主要成果:
- 在各种心血管疾病的动物模型中取得了显著的成功.
- 在临床应用中取得的成功有限,早期试验中很少有积极的结果.
- 持续存在的障碍包括基因转导效率低和不良的免疫反应.
结论:
- 心脏基因治疗具有潜力,但需要进一步的研究来克服现有的局限性.
- 解决载体效率和免疫性方面的挑战对于临床成功至关重要.
- 对安全有效的基因传递的持续研究对于推进心血管疾病治疗至关重要.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
139
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
139
Regulation of the Cardiovascular System
485
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
485
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110


